Status:
COMPLETED
Effectiveness of Ophthalmic Antiseptic Preparations
Lead Sponsor:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Collaborating Sponsors:
European School of Advanced Studies in Ophthalmology
Conditions:
Antiseptics
Microbiota
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this clinical trial is to evaluate the effectiveness of two topical antiseptics, povidone-iodine (PVI) and chlorhexidine (CHX), in reducing conjunctival bacterial flora.
Detailed Description
70 patients undergoing cataract surgery were enrolled and randomly divided in two arms: 35 patients used PVI 0.66% 4 times daily starting 3 days before surgery; 35 patients used CHX 0.02% with the sam...
Eligibility Criteria
Inclusion
- Patients undergoing cataract surgery
- 18 years of age or older
Exclusion
- Reported allergy or hypersensitivity to iodine or chlorhexidine
- Active ocular infection
- Contraindication to surgery
- Pregnant women
- Patients residing in nursing homes or prison
- Patients who used antibiotic, antiviral or antifungal eye drops in the week preceding the intervention
Key Trial Info
Start Date :
November 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05974124
Start Date
November 9 2022
End Date
February 3 2023
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Brescia, Italy, 25123